140 related articles for article (PubMed ID: 36268549)
21. Prediction of renal and cardiometabolic outcomes in gout during urate-lowering therapy by sonography.
Calabuig I; Marty-Ané A; Norberciak L; Budzik JF; Legrand J; Martínez-Sanchis A; Pascart T; Andrés M
Int J Rheum Dis; 2023 Dec; 26(12):2450-2459. PubMed ID: 37786305
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity and specificity of ultrasonographic features of gout in intercritical and chronic phase.
Das S; Ghosh A; Ghosh P; Lahiri D; Sinhamahapatra P; Basu K
Int J Rheum Dis; 2017 Jul; 20(7):887-893. PubMed ID: 27529533
[TBL] [Abstract][Full Text] [Related]
23. Brief Report: Monosodium Urate Monohydrate Crystal Deposits Are Common in Asymptomatic Sons of Patients With Gout: The Sons of Gout Study.
Abhishek A; Courtney P; Jenkins W; Sandoval-Plata G; Jones AC; Zhang W; Doherty M
Arthritis Rheumatol; 2018 Nov; 70(11):1847-1852. PubMed ID: 29806203
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound Features of the First Metatarsophalangeal Joint in Gout and Asymptomatic Hyperuricemia: Comparison With Normouricemic Individuals.
Stewart S; Dalbeth N; Vandal AC; Allen B; Miranda R; Rome K
Arthritis Care Res (Hoboken); 2017 Jun; 69(6):875-883. PubMed ID: 27635596
[TBL] [Abstract][Full Text] [Related]
25. Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition: concordance between readers.
Howard RG; Pillinger MH; Gyftopoulos S; Thiele RG; Swearingen CJ; Samuels J
Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1456-62. PubMed ID: 21702086
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for the formation of double-contour sign and tophi in gout.
Sun C; Qi X; Tian Y; Gao L; Jin H; Guo H
J Orthop Surg Res; 2019 Jul; 14(1):239. PubMed ID: 31358044
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of gout by ultrasound.
Thiele RG; Schlesinger N
Rheumatology (Oxford); 2007 Jul; 46(7):1116-21. PubMed ID: 17468505
[TBL] [Abstract][Full Text] [Related]
28. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
[TBL] [Abstract][Full Text] [Related]
29. An optimal ultrasonographic diagnostic test for early gout: A prospective controlled study.
Norkuviene E; Petraitis M; Apanaviciene I; Virviciute D; Baranauskaite A
J Int Med Res; 2017 Aug; 45(4):1417-1429. PubMed ID: 28617199
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound sensitivity to changes in gout: a longitudinal study after two years of treatment.
Peiteado D; Villalba A; Martín-Mola E; Balsa A; De Miguel E
Clin Exp Rheumatol; 2017; 35(5):746-751. PubMed ID: 28281462
[TBL] [Abstract][Full Text] [Related]
31. Tophus size is associated with hallux valgus deformity in gout.
Blandin C; Forien M; Gardette A; Palazzo E; Dieudé P; Ottaviani S
Eur J Clin Invest; 2018 Jan; 48(1):. PubMed ID: 29171878
[TBL] [Abstract][Full Text] [Related]
32. Two-year reduction of dual-energy CT urate depositions during a treat-to-target strategy in gout in the NOR-Gout longitudinal study.
Uhlig T; Eskild T; Karoliussen LF; Sexton J; Kvien TK; Haavardsholm EA; Dalbeth N; Hammer HB
Rheumatology (Oxford); 2022 Apr; 61(SI):SI81-SI85. PubMed ID: 34247224
[TBL] [Abstract][Full Text] [Related]
33. Ultrasonographic Features of Lower-Limb Joints in Gout: Which Joints and Clinical Characteristics Would Provide More Information for Diagnosis?
Zhang W; Jin Z; Xiang W; Wu M; Wang S; Zhang H; Zhang P
J Clin Rheumatol; 2020 Jan; 26(1):14-18. PubMed ID: 30234671
[TBL] [Abstract][Full Text] [Related]
34. [Risk factors and diagnostic value for ultrasound-detected tendon monosodium urate crystal deposition in patients with gout].
Wang Y; Deng XR; Ji LL; Zhang XH; Geng Y; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 53(1):143-149. PubMed ID: 33550349
[TBL] [Abstract][Full Text] [Related]
35. Performance of Ultrasound in the Clinical Evaluation of Gout and Hyperuricemia.
Cao L; Zhao T; Xie C; Zheng S; Wan W; Zou H; Zhu X
J Immunol Res; 2021; 2021():5550626. PubMed ID: 33884273
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors of tumour necrosis inhibitor treatment persistence for rheumatoid arthritis: An observational study in 8052 patients.
Fautrel B; Belhassen M; Hudry C; Woronoff-Lemsi MC; Levy-Bachelot L; Van Ganse E; Tubach F
Joint Bone Spine; 2020 Mar; 87(2):137-139. PubMed ID: 31669808
[TBL] [Abstract][Full Text] [Related]
37. Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard.
Ogdie A; Taylor WJ; Neogi T; Fransen J; Jansen TL; Schumacher HR; Louthrenoo W; Vazquez-Mellado J; Eliseev M; McCarthy G; Stamp LK; Perez-Ruiz F; Sivera F; Ea HK; Gerritsen M; Cagnotto G; Cavagna L; Lin C; Chou YY; Tausche AK; Lima Gomes Ochtrop M; Janssen M; Chen JH; Slot O; Lazovskis J; White D; Cimmino MA; Uhlig T; Dalbeth N
Arthritis Rheumatol; 2017 Feb; 69(2):429-438. PubMed ID: 27748084
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study.
Hammer HB; Karoliussen L; Terslev L; Haavardsholm EA; Kvien TK; Uhlig T
Ann Rheum Dis; 2020 Nov; 79(11):1500-1505. PubMed ID: 32669301
[TBL] [Abstract][Full Text] [Related]
39. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
[TBL] [Abstract][Full Text] [Related]
40. Systemic staging for urate crystal deposits with dual-energy CT and ultrasound in patients with suspected gout.
Huppertz A; Hermann KG; Diekhoff T; Wagner M; Hamm B; Schmidt WA
Rheumatol Int; 2014 Jun; 34(6):763-71. PubMed ID: 24619560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
